KEGG   DRUG: Samalizumab
Entry
D09961                      Drug                                   
Name
Samalizumab (USAN/INN)
Formula
C6542H10086N1702O2102S46
Exact mass
147594.1810
Mol weight
147685.29
Sequence
(Heavy chain)
QVQLQQSGSE LKKPGASVKI SCKASGYSFT DYIILWVRQN PGKGLEWIGH IDPYYGSSNY
NLKFKGRVTI TADQSTTTAY MELSSLRSED TAVYYCGRSK RDYFDYWGQG TTLTVSSAST
KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
SLSSVVTVPS SNFGTQTYTC NVDHKPSNTK VDKTVERKCC VECPPCPAPP VAGPSVFLFP
PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
CSVMHEALHN HYTQKSLSLS LG
(Light chain)
DIQMTQSPSS LSASIGDRVT ITCKASQDIN SYLSWFQQKP GKAPKLLIYR ANRLVDGVPS
RFSGSGSGTD YTLTISSLQP EDFAVYYCLQ YDEFPYTFGG GTKLEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H144-H200, H257-H317, H363-H421, H219-H'219, H220-H'220, H223-H'223, H226-H'226, L23-L88, L134-L194, H131-L214)
  Type
Peptide
Efficacy
Antineoplastic, Anti-CD200 antibody
  Type
Monoclonal antibody
Target
CD200 [HSA:4345] [KO:K06556]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD200
     D09961  Samalizumab (USAN/INN)
Other DBs
PubChem: 124490632
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system